RxDoctor Payments Data

Aadel Chaudhuri, MD

Radiation Oncology · Rochester, MNNPI 1487097572

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $25,319 of the $37,238 with a category attached, or 68.0%. 13 manufacturers reported payments, led by Roche Sequencing Solutions, Inc. at 35.6% of the total. Reporting peaked in 2022 at $12,565 and has fallen 59.5% since, to $5,084 in 2025. Among radiation oncology clinicians in MN with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$37,238in general payments, 2019–2025

Across 32 payments — averaging $1163.68 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Roche Sequencing Solutions, Inc.$13K
  • Daiichi Sankyo Inc.$8K
  • Astrazeneca UK Limited$6K
  • Agilent Technologies, Inc.$3K
  • Illumina, Inc.$2K
  • Life Technologies Corporation$2K
  • plus $3K from 7 others
$168,399in research payments, 2019–2025

Across 5 payments — averaging $33,680 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Roche Sequencing Solutions, Inc.$168K

What the payments were for

  • Consulting fees$25,31968%
  • Speaking & faculty fees$10,50028%
  • Travel & lodging$9543%
  • Food & beverage$4641%

General payments by program year

19
20
21
22
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$37,238 in reported general payments places this provider in the 95th percentile of 128 radiation oncology providers in Minnesota.

See all radiation oncology providers in Minnesota

Medicare billing

Part B allowed, 2024
$17,945
Medicare patients
43
Services billed
170

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other radiation oncology in Rochester

See the full list for Minnesota

Where these figures come from

Is this you, or does something look wrong? →